Clearmind Medicine Inc. (NASDAQ:CMND) Short Interest Update

Clearmind Medicine Inc. (NASDAQ:CMNDGet Free Report) was the target of a large decrease in short interest in the month of May. As of May 31st, there was short interest totalling 105,700 shares, a decrease of 35.3% from the May 15th total of 163,300 shares. Approximately 3.6% of the company’s shares are short sold. Based on an average daily trading volume, of 239,000 shares, the short-interest ratio is currently 0.4 days.

Clearmind Medicine Stock Performance

Clearmind Medicine stock opened at $0.86 on Monday. The firm has a 50 day simple moving average of $0.97 and a 200-day simple moving average of $1.19. Clearmind Medicine has a 1-year low of $0.80 and a 1-year high of $2.30. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.72 and a quick ratio of 1.72. The stock has a market cap of $3.66 million, a price-to-earnings ratio of -0.46 and a beta of 0.91.

Clearmind Medicine (NASDAQ:CMNDGet Free Report) last posted its quarterly earnings results on Thursday, June 12th. The company reported ($0.16) earnings per share for the quarter.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Clearmind Medicine stock. Citadel Advisors LLC increased its stake in shares of Clearmind Medicine Inc. (NASDAQ:CMNDFree Report) by 115.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 38,158 shares of the company’s stock after purchasing an additional 20,429 shares during the period. Citadel Advisors LLC owned approximately 0.89% of Clearmind Medicine worth $53,000 at the end of the most recent reporting period. Institutional investors own 96.05% of the company’s stock.

About Clearmind Medicine

(Get Free Report)

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.

Featured Stories

Receive News & Ratings for Clearmind Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clearmind Medicine and related companies with MarketBeat.com's FREE daily email newsletter.